KLF4 and cancer: Given the pivotal role of antibodies in anti‐tumor immunity, particularly in mediating cancer cell clearance and long‐term protection, these findings suggest that understanding and manipulating KLF4 signaling in plasma cells holds significant therapeutic potential for enhancing antibody‐mediated cancer immunotherapy.